Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-09-28 4:11 pm Purchase | 13G | DENALI THERAPEUTICS INC DNLI | BIOGEN INC. BIIB | 13,310,243 11.16% | 13,310,243 (New Position) | View |
| 2020-04-17 4:13 pm Purchase | 13G | SANGAMO THERAPEUTICS INC SGMO | BIOGEN INC. BIIB | 24,420,157 17.37% | 24,420,157 (New Position) | View |
| 2020-02-12 2:40 pm Purchase | 13G | BIOGEN INC BIIB | PRIMECAP MANAGEMENT CO | 15,189,481 8.42% | 462,214 (+3.14%) | View |
| 2020-02-12 11:01 am Sale | 13G | BIOGEN INC BIIB | VANGUARD GROUP INC | 13,870,538 7.68% | -1,300,069 (-8.57%) | View |
| 2020-02-11 4:58 pm Sale | 13G | IONIS PHARMACEUTICALS INC IONS | BIOGEN INC. BIIB | 5,750,577 4.1% | -5,750,576 (-50.00%) | View |
| 2020-02-11 4:56 pm Sale | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | BIOGEN INC. BIIB | 0 0% | -1,453,957 (Position Closed) | View |
| 2020-02-05 11:25 am Sale | 13G | BIOGEN INC BIIB | BlackRock Inc. BLK | 15,658,641 8.7% | -910,322 (-5.49%) | View |